| Elizabeth Lapioli, MSN, FNP-C | |
|
6553 E Baywood Ave Ste 209, Mesa, AZ 85206-1754 | |
| (480) 712-4600 | |
| Not Available |
| Full Name | Elizabeth Lapioli |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 6553 E Baywood Ave Ste 209, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619500089 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Recovia Llc | 1456629211 | 16 |
News Archive
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
AARP's national CEO William (Bill) Novelli was joined by Governor Arnold Schwarzenegger this morning at the Pasadena Convention Center for the first of a series of AARP forums on California health care reform.
› Verified 4 days ago
| Entity Name | Recovia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427421098 PECOS PAC ID: 1456629211 Enrollment ID: O20170620000742 |
News Archive
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
AARP's national CEO William (Bill) Novelli was joined by Governor Arnold Schwarzenegger this morning at the Pasadena Convention Center for the first of a series of AARP forums on California health care reform.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Lapioli, MSN, FNP-C 6553 E Baywood Ave Ste 209, Mesa, AZ 85206-1754 Ph: (480) 712-4600 | Elizabeth Lapioli, MSN, FNP-C 6553 E Baywood Ave Ste 209, Mesa, AZ 85206-1754 Ph: (480) 712-4600 |
News Archive
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
AARP's national CEO William (Bill) Novelli was joined by Governor Arnold Schwarzenegger this morning at the Pasadena Convention Center for the first of a series of AARP forums on California health care reform.
› Verified 4 days ago